T45.522 Poisoning by antithrombotic drugs, intentional self-harm

Name of the Condition

• Poisoning by antithrombotic drugs, intentional self-harm (ICD-10 code T45.522)

Summary

This condition involves harmful effects resulting from intentional self-harm through exposure to antithrombotic drugs. Antithrombotic agents are used to prevent or treat blood clots, and intentional poisoning occurs when the exposure is deliberate, leading to abnormal clotting or bleeding.

Causes

Intentional self-harm may result from deliberate ingestion or administration of antithrombotic drugs. This can occur due to suicidal intent, self-injurious behavior, or attempts to manipulate therapeutic outcomes. The severity depends on the dose, type of drug, and individual factors.

Risk Factors

• History of mental health conditions, such as depression or suicidal ideation.
• Access to antithrombotic medications in the home or clinical setting.
• Prior episodes of self-harm or overdose.
• Social or environmental stressors contributing to intentional actions.

Symptoms

• Unusual or excessive bleeding (e.g., bruising, nosebleeds, gastrointestinal bleeding).
• Prolonged bleeding from minor injuries.
• Blood in urine or stool.
• Dizziness, weakness, or fatigue from blood loss.
• Possible signs of clotting abnormalities if underdosing occurs.

Diagnosis

Diagnosis involves reviewing medication history, assessing clinical signs of bleeding or clotting abnormalities, and conducting lab tests (e.g., INR, aPTT) to evaluate coagulation status. Physical examination and patient history help confirm intentional self-harm.

Treatment Options

Treatment focuses on stabilizing the patient, managing bleeding or clotting issues, and addressing the underlying intent. This may include antidotes, supportive care, and psychiatric evaluation. Specific interventions depend on the drug type and severity.

Prognosis and Follow-Up

Prognosis varies based on the extent of exposure, timely intervention, and underlying health. Follow-up includes monitoring for complications, assessing mental health needs, and ensuring adherence to safety measures. Long-term care may involve psychiatric support.

Complications

• Severe or life-threatening bleeding.
• Organ damage from prolonged clotting or bleeding.
• Psychological sequelae related to self-harm.
• Recurrence of intentional exposure if underlying issues are unaddressed.

Lifestyle & Prevention

• Secure storage of antithrombotic medications to limit access.
• Education on proper medication use and disposal.
• Mental health support for individuals at risk of self-harm.
• Regular follow-up with healthcare providers to address concerns.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm with antithrombotic drugs is suspected or confirmed. Signs of severe bleeding, dizziness, or altered consciousness require urgent care. Mental health professionals should be involved for ongoing support.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this distinguishes T45.522 from other poisoning codes. Include details about the drug, dose, and clinical presentation to support accurate coding. Ensure alignment with clinical documentation guidelines for self-harm encounters.